Delos Wealth Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Delos Wealth Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16	Closed	-$174	–	387
2023 Q3	$174	Hold	16	–	–	﹤0.01%	356
2023 Q2	$177	Hold	16	–	–	﹤0.01%	354
2023 Q1	$215	Hold	16	–	–	﹤0.01%	362
2022 Q4	$198	Hold	16	–	–	﹤0.01%	368
2022 Q3	$0	Buy	+16	New	+$258	﹤0.01%	398

Delos Wealth Advisors's ICPT Position: Q4 2023 in Review

Delos Wealth Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 16 shares — an estimated $174 sold.

Delos Wealth Advisors first reported a position in ICPT in Q3 2022 and held it in 5 quarters. The position peaked at $215 in Q1 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Delos Wealth Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Delos Wealth Advisors sold 16 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $174.
Delos Wealth Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2022 and held it in 5 quarters.
Delos Wealth Advisors's Intercept Pharmaceuticals, Inc. position peaked at $215 in Q1 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Delos Wealth Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.